首页> 外文期刊>Indian journal of surgical oncology >Expression Levels of Il-6 and Il-18 in Acute Myeloid Leukemia and Its Relation with Response to Therapy and Acute GvHD After Bone Marrow Transplantation
【24h】

Expression Levels of Il-6 and Il-18 in Acute Myeloid Leukemia and Its Relation with Response to Therapy and Acute GvHD After Bone Marrow Transplantation

机译:IL-6和IL-18在急性髓性白血病中的表达水平及其与骨髓移植后对治疗和急性GVHD的关系

获取原文
       

摘要

Cytokines seem to play a crucial role in physiological and pathological conditions of acute myeloid leukemia (AML). The aim of this study was to evaluate the expression levels of interleukins-6 (IL-6) and IL-18 in patients with AML and its correlation with response to therapy and graft versus host disease (GvHD) after bone marrow transplantation. The expression levels of IL-6 and IL-18 genes were done in all patients and compared with matched control. Complete remission (CR) was used for evaluation of the effects of these cytokines on response to treatment in patients group. The expression level of these cytokines was also evaluated in patients who underwent bone marrow transplantation and experienced acute GvHD in compare with patients without aGvHD. Il-6 gene expression level was significantly higher in these patients in comparison with control but Il-18 gene expression level was not statistically significant compared to control group. Il-6 and also Il-18 expression levels were significantly higher in patients without a response to treatment according to CR compared to patient’s whit response to treatment as well as patients experienced aGvHD after bone marrow transplantation. IL-6 and Il-18 are important markers in the progression of the disease and could be considered as a prognostic marker in acute leukemia. It is recommended that more studies with larger study groups and more involved cytokines are needed for more evaluation of the cytokine roles in pathophysiology and progression of acute leukemia.
机译:细胞因子似乎在急性髓性白血病(AML)的生理和病理条件下发挥着至关重要的作用。本研究的目的是评估白细胞介素-6(IL-6)和IL-18在患者患者中的表达水平及其与骨髓移植后对治疗和移植物与宿主疾病(GVHD)的相关性的相关性。所有患者中,IL-6和IL-18基因的表达水平并与匹配对照进行比较。完全缓解(Cr)用于评估这些细胞因子对患者组治疗的反应的影响。在与没有AGVHD的患者的比较方面,还评估了这些细胞因子的表达水平。与对照组相比,这些患者中,这些患者IL-6基因表达水平显着较高,但与对照组相比,IL-18基因表达水平没有统计学意义。患者IL-6和IL-18表达水平显着高于根据CR的治疗与患者对治疗的惠特对治疗以及骨髓移植后的患者相比,患者的粉丝反应进行了反应。 IL-6和IL-18是疾病进展中的重要标记,并且可以被认为是急性白血病中的预后标志物。建议需要更多的研究组和更多涉及细胞因子的研究,以便更多地评估急性白血病病理生理学和进展中的细胞因子作用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号